141 related articles for article (PubMed ID: 9192799)
41. The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells.
Rettinger E; Kuçi S; Naumann I; Becker P; Kreyenberg H; Anzaghe M; Willasch A; Koehl U; Bug G; Ruthardt M; Klingebiel T; Fulda S; Bader P
Cytotherapy; 2012 Jan; 14(1):91-103. PubMed ID: 21973023
[TBL] [Abstract][Full Text] [Related]
42. Differential diagnosis of malignant lymphomas and related disorders by specific pattern of expression of immunophenotypic markers revealed by multiparameter flow cytometry (Review).
Weisberger J; Wu CD; Liu Z; Wong JY; Melamed MR; Darzynkiewicz Z; Gorczyca W
Int J Oncol; 2000 Dec; 17(6):1165-77. PubMed ID: 11078802
[TBL] [Abstract][Full Text] [Related]
43. Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient.
Kawano S; Tatsumi E; Yoneda N; Yamaguchi N; Goji J; Ito H; Nagai T; Nishikori M; Okamura A; Koiwai O
Hematol Oncol; 1995; 13(1):1-11. PubMed ID: 7538482
[TBL] [Abstract][Full Text] [Related]
44. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement.
Liu XY; Atkins RC; Feusner JH; Rowland JM
Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822
[TBL] [Abstract][Full Text] [Related]
45. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
[TBL] [Abstract][Full Text] [Related]
46. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
Souabni A; Jochum W; Busslinger M
Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
[TBL] [Abstract][Full Text] [Related]
47. Aggressive variant of morphologically typical T large granular lymphocyte leukemia/lymphoma lacking NK cell markers.
Passetto Falcão R; Pinto Simões B; Garcia AB; Fonseca BA; Terra Filho J
Acta Haematol; 2000; 104(2-3):110-4. PubMed ID: 11154985
[TBL] [Abstract][Full Text] [Related]
48. Lymphoblastic lymphoma of natural killer cell origin, presenting as pancreatic tumour.
Tamura H; Ogata K; Mori S; An E; Tajika K; Sugisaki Y; Dan K
Histopathology; 1998 Jun; 32(6):508-11. PubMed ID: 9675589
[TBL] [Abstract][Full Text] [Related]
49. Killer T-cell induction in patients with blastic natural killer cell lymphoma/leukaemia: implications for successful treatment and possible therapeutic strategies.
Yamada O; Ichikawa M; Okamoto T; Park C; Motoji T; Mizoguchi H; Shibuya A
Br J Haematol; 2001 Apr; 113(1):153-60. PubMed ID: 11328295
[TBL] [Abstract][Full Text] [Related]
50. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
51. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.
Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M
Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726
[TBL] [Abstract][Full Text] [Related]
52. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
53. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
[TBL] [Abstract][Full Text] [Related]
54. Monoclonal origin of concordant T-cell malignancy in identical twins.
Ford AM; Pombo-de-Oliveira MS; McCarthy KP; MacLean JM; Carrico KC; Vincent RF; Greaves M
Blood; 1997 Jan; 89(1):281-5. PubMed ID: 8978302
[TBL] [Abstract][Full Text] [Related]
55. Immunophenotyping of 515 cases of acute lymphoblastic leukemia in China.
Bai Y; Shen MY; Zhang DF; Lai CN; Chen Y; Sun YX; Yang ZG
Sci China B; 1991 Nov; 34(11):1319-28. PubMed ID: 1801840
[TBL] [Abstract][Full Text] [Related]
56. [Acute lymphocytic leukemia having surface phenotype of CD 2 and NKH-1 with rapid clinical course].
Yamamoto M; Nishinarita S; Furuta K; Takeuchi J; Horikoshi A; Iizuka Y; Kubo N; Amaki S; Shida M; Kinukawa N
Rinsho Ketsueki; 1990 Jul; 31(7):969-73. PubMed ID: 1699009
[TBL] [Abstract][Full Text] [Related]
57. [Aggressive natural killer cell leukemia/lymphoma--possible existence of a new clinical entity originating from the third lineage of lymphoid cells].
Imamura N; Kusunoki Y; Oda K; Abe K; Dohi H; Inada T; Kuramoto A; Kajihara H; Fujii H; Kawa K
Rinsho Ketsueki; 1989 Feb; 30(2):193-201. PubMed ID: 2664262
[TBL] [Abstract][Full Text] [Related]
58. Minimal residual disease in acute myelogenous leukemia with PML/RAR alpha or AML1/ETO mRNA and phenotypic analysis of possible T and natural killer cells in bone marrow.
Inokuchi K; Iwakiri R; Futaki M; Hanawa H; Tanosaki S; Nomura T; Dan K
Leuk Lymphoma; 1998 May; 29(5-6):553-61. PubMed ID: 9643569
[TBL] [Abstract][Full Text] [Related]
59. A T-lineage neoplasm-Which one?
Bain BJ; Fawcett N
Am J Hematol; 2009 Oct; 84(10):678. PubMed ID: 19373891
[No Abstract] [Full Text] [Related]
60. Definition of acute biphenotypic leukemia.
Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
